Greenhalgh Ellis Skott 4
4 · TELA Bio, Inc. · Filed Feb 26, 2021
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Greenhalgh Ellis Skott
Chief Science Officer
Transactions
- Award
Common Stock
2021-02-24+11,600→ 22,110 total - Award
Stock Option (right to buy)
2021-02-24+21,000→ 21,000 totalExercise: $16.99Exp: 2031-02-24→ Common Stock (21,000 underlying)
Footnotes (2)
- [F1]These restricted stock units will vest in four equal annual installments beginning on February 24, 2022, subject to the Reporting Person's continuous service with the Issuer.
- [F2]The option vests 25% on February 24, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continuous service with the Issuer.